Re: Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923–932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933–945) Correspondence
| Authors: | Abramson, D. H.; Shields, C. L. |
| Title: | Re: Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923–932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933–945) |
| Keywords: | clinical feature; advanced cancer; nuclear magnetic resonance imaging; follow up; letter; metastasis; retinoblastoma; echography; intraarterial drug administration; human |
| Journal Title: | Ophthalmology |
| Volume: | 130 |
| Issue: | 3 |
| ISSN: | 0161-6420 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2023-03-01 |
| Start Page: | e11 |
| End Page: | e12 |
| Language: | English |
| DOI: | 10.1016/j.ophtha.2022.10.018 |
| PUBMED: | 36443123 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 1 March 2023 -- Source: Scopus |
